Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 19, Issue 6

2012 December - 22 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (22)

  • Article
  • Open Access
37 Citations
1,550 Views
8 Pages

1 December 2012

Objective: Our understanding of optimum health care delivery for cancer survivors is limited by the lack of a patient-centred perspective. The objectives of the present study were to explore the views of breast and colorectal cancer survivors on thei...

  • Article
  • Open Access
3 Citations
1,062 Views
6 Pages

1 December 2012

Most patients with gastric or gastroesophageal junction (GEJ) cancer are diagnosed with inoperable advanced or metastatic disease. In these cases, chemotherapy is the only treatment demonstrating survival benefit. The present study compares clinicopa...

  • Article
  • Open Access
10 Citations
1,240 Views
7 Pages

Extended Adjuvant Temozolomide with cis-Retinoic Acid for Adult Glioblastoma

  • M.W. Pitz,
  • M. Lipson,
  • B. Hosseini,
  • P. Lambert and ,
  • K. Guilbert,
  • D. Lister,
  • G. Schroeder,
  • K. Jones,
  • C. Mihalicioiu and
  • D.D. Eisenstat
  • + 5 authors+ 0 author

1 December 2012

Objective: To determine the toxicity and effectiveness of 24 months of adjuvant temozolomide (TMZ) with cis-retinoic acid (CRA) for patients with glioblastoma. Methods: This retrospective population-based review considered the charts of all patients...

  • Review
  • Open Access
12 Citations
1,268 Views
9 Pages

Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada

  • W. Hanna,
  • P. Barnes,
  • R. Berendt,
  • M. Chang and ,
  • A. Magliocco,
  • A.M. Mulligan,
  • H. Rees,
  • N. Miller,
  • L. Elavathil and
  • S. SenGupta
  • + 8 authors+ 3 authors

1 December 2012

This review is designed to highlight several key challenges in the diagnosis of human epidermal growth factor receptor 2 (HER2)–positive breast cancer currently faced by pathologists in Canada: (1) Pre-analysis issues affecting the accuracy of HER2 t...

  • Review
  • Open Access
779 Views
3 Pages

A Retrospective Chart Review Validates Indicator Results and Provides Insight into Reasons for Non-Concordance with Evidence-Based Guidelines

  • J. Klein–Geltink,
  • T. Forte,
  • R. Rahal,
  • J. Niu and ,
  • D. He,
  • G. Lockwood,
  • W. Cheung,
  • G. Darling and
  • H. Bryant
  • + 4 authors+ 0 author

1 December 2012

As part of the system performance initiative of the Canadian Partnership Against Cancer, indicators measuring treatment practice patterns across the country relative to evidence-based guidelines were first published in 2010 and are updated annually....

  • Short Communication
  • Open Access
20 Citations
1,033 Views
3 Pages

1 December 2012

Chemotherapy in the adjuvant setting for early breast cancer (EBC) has improved disease-free and overall survival, with benefits extended to elderly patients and to those with lymph-node-negative pathology. [...]

  • Commentary
  • Open Access
67 Citations
3,132 Views
7 Pages

1 December 2012

Canada is facing cancer crisis. Cancer has become the leading cause of death in Canada. Despite recent advances in cancer management and research, growing disparities in cancer care have been noticed, especially in socio-economically disadvantaged gr...

  • Article
  • Open Access
14 Citations
1,269 Views
9 Pages

Population-Based Home Care Services in Breast Cancer: Utilization and Costs

  • N. Mittmann,
  • P.K. Isogai,
  • R. Saskin,
  • N. Liu and ,
  • J.M. Porter,
  • M.C. Cheung,
  • N.B. Leighl,
  • J.S. Hoch,
  • M.E. Trudeau and
  • C.C. Earle
  • + 7 authors+ 2 authors

1 December 2012

Objective: To determine utilization and costs of home care services (HCS) for individuals with a diagnosis of breast cancer (BC). Methods: Incident cases of invasive BC in women were extracted from the Ontario Cancer Registry (2005–2009) and linked w...

  • Article
  • Open Access
12 Citations
1,240 Views
12 Pages

Cost-Effectiveness of Zoledronic Acid Compared with Clodronate in Multiple Myeloma

  • T.E. Delea,
  • K. El Ouagari,
  • J. Rotter,
  • A. Wang and ,
  • S. Kaura and
  • G.J. Morgan
  • + 1 author+ 0 author

1 December 2012

Background: In the U.K. Medical Research Council Myeloma IX trial (mmix), zoledronic acid 4 mg once every 3–4 weeks, compared with clodronate 1600 mg daily, reduced the incidence of skeletal related events (sres), increased progression-free survival...

  • Article
  • Open Access
43 Citations
1,592 Views
10 Pages

1 December 2012

Background: Timeliness of care (rapid initiation of treatment after definitive diagnosis) is a key component of high-quality cancer treatment. The present study evaluated factors influencing timeliness of care for U.S. Medicare enrollees. Methods: Da...

  • Article
  • Open Access
54 Citations
1,857 Views
8 Pages

Prospective Validation of Risk Prediction Indexes for Acute and Delayed Chemotherapy-Induced Nausea and Vomiting

  • N. Bouganim,
  • G. Dranitsaris,
  • S. Hopkins,
  • L. Vandermeer and ,
  • L. Godbout,
  • S. Dent,
  • P. Wheatley–Price,
  • C. Milano and
  • M. Clemons
  • + 4 authors+ 0 author

1 December 2012

Background: Despite the use of standardized anti-emetic guidelines, up to 20% of cancer patients suffer from moderate-to-severe chemotherapy-induced nausea and vomiting (CINV)—that is, grade 2 or greater according to the U.S. National Cancer Institut...

  • Article
  • Open Access
5 Citations
997 Views
6 Pages

1 December 2012

Background: Clinical trials demonstrate improved survival for patients with completely resected non-small-cell lung cancer (NSCLC) who receive adjuvant chemotherapy. Concerns have been raised about the implementation of those data. The present study...

  • Article
  • Open Access
4 Citations
940 Views
8 Pages

1 December 2012

Background: he increasing cost of cancer drugs underscores the importance of economic analyses. Although guide-lines for abstract reporting of randomized controlled studies and phase i trials are available, similar rec-ommendations for conference abs...

  • Review
  • Open Access
67 Citations
2,670 Views
26 Pages

A Systematic Review of Integrative Oncology Programs

  • D.M. Seely,
  • L.C. Weeks and
  • S. Young

1 December 2012

Objective: This systematic review set out to summarize the research literature describing integrative oncology programs. Methods: Searches were conducted of 9 electronic databases, relevant journals (hand searched), and conference abstracts, and expe...

  • Review
  • Open Access
21 Citations
1,342 Views
6 Pages

1 December 2012

Melanoma is the most dangerous form of skin cancer, and its incidence is increasing significantly among Canadians. In parallel with the rising incidence and morbidity, the financial burden caused by this disease will continue to increase dramatically...

  • Article
  • Open Access
1 Citations
1,084 Views
10 Pages

Report from the 13th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; September 8–10, 2011

  • M.M. Vickers,
  • J. Pasieka,
  • E. Dixon,
  • S. McEwan and ,
  • A. McKay,
  • D. Renouf,
  • D. Schellenberg and
  • D. Ruether
  • + 3 authors+ 0 author

1 December 2012

The 13th annual Western Canadian Gastrointestinal Cancer Consensus Conference was held in Calgary, Alberta, September 8–10, 2011. Health care professionals involved in the care of patients with gastrointestinal cancers participated in presentation an...

  • Review
  • Open Access
50 Citations
1,985 Views
13 Pages

Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations

  • S. L’Espérance,
  • F. Vincent,
  • M. Gaudreault,
  • J.A. Ouellet and ,
  • M. Li,
  • A. Tosikyan,
  • S. Goulet and
  • + 3 authors+ 0 author

1 December 2012

Background: Metastatic spinal cord compression (MSCC) is an oncologic emergency that, unless diagnosed early and treated appropriately, can lead to permanent neurologic impairment. After an analysis of relevant studies evaluating the effectiveness of...

  • Case Report
  • Open Access
6 Citations
1,072 Views
5 Pages

1 December 2012

Successful treatment of soft-tissue sarcomas is highly dependent on total tumour resection coupled with adjuvant radiation therapy to achieve local control and decrease recurrence. Reconstruction of soft-tissue defects after resection aims to cover v...

  • Case Report
  • Open Access
16 Citations
1,538 Views
5 Pages

Perianal Paget disease treated definitively with radiotherapy

  • J. Mann,
  • A. Lavaf,
  • A. Tejwani,
  • P. Ross and
  • H. Ashamalla

1 December 2012

Extramammary Paget disease (EMPD) is a relatively rare cutaneous disorder described as an apocrine gland tumour occurring in both a benign and a malignant form with metastatic potential. The areas of the body affected are the vulva, perianal region,...

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729